Founded in 1963, bioMérieux is a world leader in the field of in vitro diagnostics. The company is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. bioMérieux products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market.